Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder
NCT ID: NCT00233675
Last Updated: 2023-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
INTERVENTIONAL
2003-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.
NCT00214994
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236015
A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236067
A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236054
Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
NCT00208741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GABITRIL (tiagabine hydrochloride; CEP-6671)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cephalon
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Brown, MD
Role: STUDY_DIRECTOR
Cephalon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pivotal Research Center
Mesa, Arizona, United States
Southwestern Research
Beverly Hills, California, United States
Pharmacology Research Institut
Newport Beach, California, United States
Pharmacology Research Institut
Northridge, California, United States
Pacific Clinical Research Medi
Orange, California, United States
Radiant Research San Diego
San Diego, California, United States
Affiliated Research Institute
San Diego, California, United States
Radiant Research Denver
Denver, Colorado, United States
University of Connecticut
Farmington, Connecticut, United States
Clinical Neuroscience Solution
Jacksonville, Florida, United States
Clinical Neuroscience Solution
West Palm Beach, Florida, United States
Carman Research
Smyrna, Georgia, United States
Cunningham Clinical Research
Edwardsville, Illinois, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Summit Research Network Farmin
Farmington Hills, Michigan, United States
CNS Research Institute
Clementon, New Jersey, United States
Social Psychiatry Research Ins
Brooklyn, New York, United States
Fieve Clinical Services, Inc.
New York, New York, United States
Medical and Behavioral
New York, New York, United States
Medical Research Network
New York, New York, United States
Richard Weisler, MD and Assoc
Raleigh, North Carolina, United States
Summit Research Network Inc.
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
South East Health Consultants
Charleston, South Carolina, United States
Claghorn-Lesem Research
Bellaire, Texas, United States
Radiant Research Salt Lake
Salt Lake City, Utah, United States
Comprehensive Neuroscience Of
Falls Church, Virginia, United States
Summit Seattle Boren
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C6671A/301/AX/US
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.